Tau-related white-matter alterations along spatially selective pathways

[1]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[2]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[3]  R A Crowther,et al.  Tau Proteins and Neurofibrillary Degeneration , 1991, Brain pathology.

[4]  R. Levy,et al.  On certain peculiar diseases of old age , 1991, History of Psychiatry.

[5]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[6]  Alejandra del C. Alonso,et al.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.

[7]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[9]  J. Schneider,et al.  Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease , 2002, Annals of neurology.

[10]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[11]  A. Dale,et al.  Age-related alterations in white matter microstructure measured by diffusion tensor imaging , 2005, Neurobiology of Aging.

[12]  Jun Yoshino,et al.  Demyelination increases radial diffusivity in corpus callosum of mouse brain , 2005, NeuroImage.

[13]  Hsiao-Fang Liang,et al.  Detecting axon damage in spinal cord from a mouse model of multiple sclerosis , 2006, Neurobiology of Disease.

[14]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[15]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[16]  Andrew L. Alexander,et al.  Hybrid diffusion imaging , 2007, NeuroImage.

[17]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[18]  Olaf Sporns,et al.  Complex network measures of brain connectivity: Uses and interpretations , 2010, NeuroImage.

[19]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[20]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[21]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[22]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[23]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[24]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[25]  Alan Connelly,et al.  MRtrix: Diffusion tractography in crossing fiber regions , 2012, Int. J. Imaging Syst. Technol..

[26]  M. Mintun,et al.  Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods , 2013, The Journal of Nuclear Medicine.

[27]  D. Louis Collins,et al.  Diffusion Weighted Image Denoising Using Overcomplete Local PCA , 2013, PloS one.

[28]  R. Mayeux,et al.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.

[29]  Andrew J. Saykin,et al.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.

[30]  Jean-Philippe Thiran,et al.  Accelerated Microstructure Imaging via Convex Optimization (AMICO) from diffusion MRI data , 2015, NeuroImage.

[31]  Robert A. Koeppe,et al.  The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET , 2015, Alzheimer's & Dementia.

[32]  Keith A. Johnson,et al.  Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.

[33]  John T. O’Brien,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License Cortical Tau Load Is Associated with White Matter Hyperintensities , 2022 .

[34]  B. Hyman,et al.  Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease , 2015, Acta neuropathologica communications.

[35]  Hanna Cho,et al.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.

[36]  Thomas W. McAllister,et al.  Age effects and sex differences in human brain white matter of young to middle-aged adults: A DTI, NODDI, and q-space study , 2016, NeuroImage.

[37]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[38]  Shannon L Risacher,et al.  The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests. , 2016, Journal of Alzheimer's disease : JAD.

[39]  W. Jagust,et al.  Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.

[40]  Robert I. Reid,et al.  White-matter integrity on DTI and the pathologic staging of Alzheimer's disease , 2017, Neurobiology of Aging.

[41]  Clifford R. Jack,et al.  Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition , 2016, Alzheimer's & dementia.

[42]  Giovanni Volpe,et al.  BRAPH: A graph theory software for the analysis of brain connectivity , 2017, bioRxiv.

[43]  C. Smart,et al.  Subjective Cognitive Decline in Preclinical Alzheimer's Disease. , 2017, Annual review of clinical psychology.

[44]  David T. Jones,et al.  Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.

[45]  Shannon L. Risacher,et al.  Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography , 2017, Alzheimer's & dementia.

[46]  John C. Morris,et al.  AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure , 2017, NeuroImage.

[47]  Alan J. Thomas,et al.  Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease , 2017, Acta Neuropathologica.

[48]  William J. Jagust,et al.  Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease , 2017, NeuroImage.

[49]  Quanzheng Li,et al.  Neurogenetic contributions to amyloid beta and tau spreading in the human cortex , 2018, Nature Medicine.

[50]  David N. Vaughan,et al.  Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment , 2018, Brain : a journal of neurology.

[51]  Brian A. Gordon,et al.  Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions , 2018, Neurology.

[52]  Jorge Sepulcre,et al.  Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.

[53]  Charles DeCarli,et al.  Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? , 2018, Brain : a journal of neurology.

[54]  Shannon L. Risacher,et al.  Topographic staging of tau positron emission tomography images , 2018, Alzheimer's & dementia.

[55]  Olivier Salvado,et al.  Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? , 2018, Brain : a journal of neurology.

[56]  Martin Rossor,et al.  White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease , 2018, Brain : a journal of neurology.

[57]  J. Whitwell,et al.  Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.

[58]  Thomas W. McAllister,et al.  Hybrid Diffusion Imaging in Mild Traumatic Brain Injury , 2018, Journal of neurotrauma.

[59]  Shannon L. Risacher,et al.  White matter alterations in early-stage Alzheimer's disease: A tract-specific study , 2019, Alzheimer's & dementia.

[60]  Christopher G Schwarz,et al.  Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease , 2018, Human brain mapping.

[61]  Rik Ossenkoppele,et al.  Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity , 2019, eLife.